Breaking News, Collaborations & Alliances

PharmaMar Forms License Agreement For Aplidin

Teams up with Specialised Therapeutics Australia

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company Specialised Therapeutics Australia Pty (STA) to market and distribute the drug candidate Aplidin (plitidepsin) in Australia and New Zealand. PharmaMar will receive an upfront payment, royalties as well as additional remunerations for regulatory and sales milestones achieved by Aplidin. PharmaMar will retain exclusive production rights and will supply the finished product to STA for com...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters